Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study

Ticiana De Francesco, Huixin Anna Zhang, Vital P Costa, Iqbal Ike K Ahmed · 2026

Read Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study by Ticiana De Francesco, Huixin Anna Zhang, Vital P Costa, Iqbal Ike K Ahmed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13271431.txt.

Description

Ticiana De Francesco is lead author of a 2026 multicentre study comparing two tiny drainage devices for glaucoma, the Xen63 gel stent and the Preserflo microshunt. Both lower eye pressure by draining fluid. Both were implanted alone, with a drug to limit scarring, in this study looking back at past cases.

At twelve months, complete success was about sixty-two percent for Xen63 and about seventy-four percent for Preserflo. Complete success meant pressure controlled without glaucoma medicines under strict rules. That gap was not statistically clear. Complications were more frequent with Xen63, at about sixty-two percent against about twenty-nine percent. Reoperations were also more common, at about seventeen percent against four percent. Pressure reduction and medicine burden were otherwise comparable.

Catalog record

CREATORTiciana De Francesco, Huixin Anna Zhang, Vital P Costa, Iqbal Ike K Ahmed
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51793
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13271431

Browse the full library · About the Tower of Babel